| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,126,000 | 6,363,000 | 5,735,000 | 5,805,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 6,126,000 | 6,363,000 | 5,735,000 | 5,805,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,012,000 | 4,174,000 | 3,972,000 | 3,809,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 766,000 | 1,154,000 | 944,000 | 975,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,348,000 | 1,035,000 | 819,000 | 1,021,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,348,000 | 1,035,000 | 819,000 | 1,021,000 | | Interest Expense | 98,000 | 94,000 | 92,000 | 94,000 | | Income Before Tax | 1,250,000 | 941,000 | 727,000 | 927,000 | | Income Tax Expense | 315,000 | 201,000 | 65,000 | 126,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 935,000 | 740,000 | 662,000 | 801,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 935,000 | 740,000 | 662,000 | 801,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $935,000 | $740,000 | $662,000 | $801,000 |
|
1.48% Nasdaq 
Income Statement
